RSS-Feed abonnieren
DOI: 10.1055/s-2003-36782
Synthesis of the Tricyclic Core of the Marine Alkaloid Lepadiformine
Publikationsverlauf
Publikationsdatum:
22. Januar 2003 (online)
Abstract
A stereoselective synthesis of the tricyclic core in racemic form of the marine alkaloid Lepadiformine is described from 4-methoxy-3-pyrrolin-2-one (methyl tetramate). Key steps involve 5,5-dialkylation of the tetramate, metathesis closure to an A/C 1-azaspirocycle and stereoselective hydrogenation for the trans A/B 1-azadecalin system.
Key words
marine alkaloid - metathesis - silyloxypyrrole alkylation - tetramate reduction - 1-azaspiro[4.5]decane
- 1
Biard JF.Guyot S.Roussakis C.Verbist JF.Vercauteren J.Weber JF.Boukef K. Tetrahedron Lett. 1994, 35: 2691 - 2
Juge M.Grimaud N.Biard JF.Sauviat MP.Nabil M.Verbist JF.Petit JY. Toxicon 2001, 39: 1231 -
3a
Pearson WH.Ren Y. J. Org. Chem. 1999, 64: 688 -
3b
Werner KM.De los Santos JM.Weinreb SM.Shang M. J. Org. Chem. 1999, 64: 4865 -
3c
Abe H.Aoyagi S.Kibayashi C. J. Am. Chem. Soc. 2000, 122: 4583 -
3d
Maeng JH.Funk RL. Org. Lett. 2001, 3: 3511 - 4
Sun P.Sun C.Weinreb SM. J. Org. Chem. 2002, 67: 4337 -
5a
Golden JE.Aubé J. Chemtracts 1999, 12: 1026 -
5b
Snider BB.Lin H. J. Am. Chem. Soc. 1999, 121: 7778 -
5c
Scheffler G.Seike H.Sorensen EJ. Angew. Chem. Int. Ed. 2000, 39: 4593 -
5d
Ousmer M.Braun NA.Ciufolini MA. Org. Lett. 2001, 3: 765 -
5e
Funk RL.Maeng JH. Org. Lett. 2001, 3: 1125 -
5f
Wardrop DJ.Zhang W. Org. Lett. 2001, 3: 2353 -
6a
Snider BB.Lin H. Org. Lett. 2000, 2: 643 -
6b
Wardrop DJ.Basak A. Org. Lett. 2001, 3: 1053 -
6c
Mizutani H.Takayama J.Soeda Y.Honda T. Tetrahedron Lett. 2002, 43: 2411 -
6d
Nagumo S.Nishida A.Yamazaki C.Matoba A.Murashige K.Kawahara N. Tetrahedron 2002, 58: 4917 -
7a
Kuehne ME.Horne DA. J. Org. Chem. 1975, 40: 1287 -
7b
Fujimoto RA.Boxer J.Jackson RH.Simke JP.Neale RF.Snowhill EW.Barbaz BJ.Williams M.Sills MA. J. Med. Chem. 1989, 32: 1259 -
7c
Kawase M.Kitamura T.Kikugawa Y. J. Org. Chem. 1989, 54: 3394 -
7d
Sawamura M.Nakayama Y.Tang W.-M.Ito Y. J. Org. Chem. 1996, 61: 9090 -
7e
Bagley MC.Oppolzer W. Tetrahedron: Asymmetry 2000, 11: 2625 -
8a
Jones RCF.Patience JM. J. Chem. Soc., Perkin Trans. 1 1990, 2350 -
8b
Gill GB.James GD.Oates KV.Pattenden G. J. Chem. Soc., Perkin Trans. 1 1993, 2567 - 9
Reuschling D.Pietsch H.Linkies A. Tetrahedron Lett. 1978, 615 -
10a
Casiraghi G.Rassu G. Synthesis 1995, 607 -
10b
Rassu G.Carta P.Pinna L.Battistini L.Zanardi F.Acquotti D.Casiraghi G. Eur. J. Org. Chem. 1999, 6: 1395 -
10c
Rassu G.Zanardi F.Battistini L.Casiraghi G. Chem. Soc. Rev. 2000, 29: 109 - 11
Jones RCF.Bates AD. Tetrahedron Lett. 1986, 27: 5285 - 13
Sanford MS.Ulman M.Grubbs RH. J. Am. Chem. Soc. 2001, 123: 749 - 14
Fischer R,Graff A,Bretschneider T,Erdelen C,Drewes MW, andFeucht D. inventors; WO Patent 2001023354. - 15
Laffan DP.Baenziger M.Duc L.Evans AR.McGarrity JF.Meul T. Helv. Chim. Acta 1992, 75: 892 - Prepared from the bromide:
-
17a
Kozikowski AP.Stein PD. J. Org. Chem. 1984, 49: 2301 -
17b
Ziegler FE.Klein SI.Pati UK.Wang T.-F. J. Am. Chem. Soc. 1985, 107: 2730 - 18
Hoffman RV.Bishop RD.Fitch PM.Hardenstein R. J. Org. Chem. 1980, 45: 917 - 19
Yoda H.Kitayama H.Katagiri T.Takabe K. Tetrahedron: Asymmetry 1993, 4: 1455 -
20a
Aubé J.Milligan GL. J. Am. Chem. Soc. 1991, 113: 8965 -
20b
Data for the trans diastereomer 11a, (7aS *,11aS *)-Decahydro-3H-pyrrolo[2,1-j]quinolin-3-one: IR: νmax (CH2Cl2) = 2935, 2864,1674, 1418 cm-1. Found: M+, 193.14725. C12H19NO requires M+: 193.14666. 1H NMR (400 MHz, CDCl3): δ = 1.11-1.39 (4 H, m, CH 2), 1.41-1.87 (10 H, m, CH 2), 1.93 (1 H, dd, J = 7.7, 12.3 Hz, CH2), 2.20 (1 H, dd, J = 8.8, 16.5 Hz, H-2), 2.49 (1 H, dddd, J = 0.9, 7.9, 12.6, 16.5 Hz, H-2), 2.77 (1 H, dddd, J = 1.1, 7.0, 11.2, 13.7 Hz, H-5), 3.88 (1 H, dd, J = 8.4, 13.7 Hz, H-5). 13C NMR (75 MHz, CDCl3): δ = 21.4 (CH2), 22.5 (CH2), 23.5 (CH2), 24.9 (CH2), 26.0 (CH2), 27.4 (CH2), 30.6 (CH2), 33.3 (C-5), 33.8 (C-2), 42.1 (C-7a), 64.1 (C-11a), 175.9 (C=O).
- Several papers have appeared on asymmetric synthesis of 5,5-disubstituted pyrrolidin-2-ones:
-
21a
Uno H.Baldwin JE.Russell AT. J. Am. Chem. Soc. 1994, 116: 2139 -
21b
Nagasaka T.Imai T. Heterocycles 1995, 41: 1927 -
21c
Nagasaka T.Imai T. Chem. Pharm. Bull. 1997, 45: 36 -
21d
Langlois N.Choudhury PK. Tetrahedron Lett. 1999, 40: 2525 -
21e
Schuch CM.Pilli RA. Tetrahedron: Asymmetry 2000, 11: 753 -
21f
Choudhury PK.Le Nguyen B.Langlois N. Tetrahedron Lett. 2002, 43: 463
References
The following experimental procedure for conversion of 3b to 4 applies: The substrate 3b (0.73g, 3mmol) was dissolved in anhyd THF (30 mL) under N2 and cooled to -78 °C. A solution of n-BuLi in hexane (2.25 mL of a 1.6 M solution, 3.6 mmol, 1.2 equiv) was added dropwise. After stirring for 30 min at -78 °C TMSCl (0.57 mL, 4.5 mmol, 1.5 equiv) was added dropwise and the solution was stirred for a further 30 min at -78 °C. Trimethyl orthoformate (1.00 mL, 9.0 mmol, 3 equiv) was then added, followed by BF3·OEt2 (0.57 mL, 4.5 mmol, 1.5 equiv). The reaction was allowed to slowly warm to -20 °C over 2 h. Sat. NaHCO3 solution was then added and the THF was removed by evaporation. The remaining aqueous layer was extracted with 3 portions of EtOAc. The organic layers were combined, dried and concentrated to give an oily residue. The product was isolated by column chromatography to give the acetal as an oil that slowly crystallised as a colourless, waxy solid 4 (0.699 g, 2.20 mmol) in 88% yield based on recovered starting material (0.125 g, 0.51 mmol). Data for 4: IR: νmax (CH2Cl2) = 3019, 1669, 1640, 1346 cm-1. Found: M+ (+ H), 318.17144. C18H24NO4 requires M+: 318.17053. 1H NMR (400 MHz, CDCl3): δ = 2.37 (1 H, ddt, J = 1.1, 7.7, 14.7 Hz, CH 2), 2.54 (1 H, dd, J = 6.6, 14.7 Hz, CH 2), 3.27 (3 H, s, OCH 3), 3.32 (3 H, s, OCH 3), 3.75 (3 H, s, OCH 3), 4.21 (1 H, s, OCHO), 4.61 (2 H, s, PhCH 2), 4.84 (2 H, m, CH=CH 2), 5.12 (1 H, s, H-3), 5.18 (1 H, m, CH=CH2), 7.15-7.38 (5 H, m, aromatic). 13C NMR (100 MHz, CDCl3): δ = 33.8 (CH2), 43.6 (PhCH2), 57.8, 57.9 and 58.0 (3 × OCH3), 71.8 (C-5), 95.2 (C-3), 107.6 (OCHO), 118.6 (CH=CH2), 126.6, 128.0 and 128.5 (aromatic), 130.9 (CH=CH2), 139.6 (aromatic), 172.2 (C-4), 174.5 (C=O).
16Prepared from the phosphonium bromide in ref. [17b] by treatment with KOH.